Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines
Clinical trial NCT01814670 · COMPLETED
Trial details
- NCT number
- NCT01814670
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-06
- Primary completion
- 2014-07-31
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.